You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Champoux Jennifer · SEC Form 4 · Filed Jun 18, 2026
Sale
Calculated transaction value
$41.34K
Champoux Jennifer Chief Operating Officer
GLUE
Transaction date
Jun 17, 2026
Public filing date
Jun 18, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$18.41
Jun 17, 2026
First close after public filing
$18.67
Jun 22, 2026
30-day return after filing
+25.76%
Through Jul 20, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,176 shares @ $19
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-275806
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$50K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 17, 2026 | $8.66K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jun 17, 2026 | $41.34K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 17, 2026 | $0 |